Pay to Marwadi

Company Profile

MEDPLUS HEALTH SERVICES LTD.

NSE : MEDPLUSBSE : 543427ISIN CODE : INE804L01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE667.50-15 (-2.2 % )
PREV CLOSE (Rs.) 682.50
OPEN PRICE (Rs.) 686.80
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5951
TODAY'S LOW / HIGH (Rs.)663.50 686.80
52 WK LOW / HIGH (Rs.)597.95 977.45
NSE666.85 -14.95 (-2.19 % )
PREV CLOSE(Rs.) 681.80
OPEN PRICE (Rs.) 685.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 666.85 (612 )
VOLUME 78551
TODAY'S LOW / HIGH(Rs.) 663.20 687.65
52 WK LOW / HIGH (Rs.)598.6 978

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.00
TTM EPS (Rs.) 0.45
P/E Ratio 0.00
Book Value (Rs.) 96.77
Face Value (Rs.) 2
MCap (Rs. in Mn) 79790.92
Price/Earning (TTM) 280.30
Price/Sales (TTM) 19.67
Price/Book (MRQ) 6.90
PAT Margin (%) 2.40
ROCE (%) 1.25
Incorporation Year : 2006

Management Info :

Gangadi Madhukar Reddy - Chairman Gangadi Madhukar Reddy - Managing Director

Registered Office :

Address : H. No: 11-6-56, Survey No: 257 & 258/1,Opp: I D P L Railway Siding Road,Moosapet, Kukatpally,
Hyderabad,
Telangana-500037

Phone : 040-67246724

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
26Mar03-26-2024$Medplus Health Services informs about revised disclosure Medplus Health Services info

Medplus Health Services has informed that the exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 23, 2024 for Madhukar Reddy Gangadi.

The above information is a part of company’s filings submitted to BSE.
Medplus Health Services has informed that the exchange has rece..
23Mar03-23-2024$Medplus Health Services informs about disclosures Medplus Health Services info
Medplus Health Services has informed that the Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 23, 2024 for Agilemed Investments.

The above information is a part of company’s filings submitted to BSE.
Medplus Health Services has informed that the Exchange has rece..
23Mar03-23-2024$Medplus Health Services informs about revised disclosure Medplus Health Services info

Medplus Health Services has informed that the exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 23, 2024 for Madhukar Reddy Gangadi.

The above information is a part of company’s filings submitted to BSE.

Medplus Health Services has informed that the exchange has rece..
06Mar03-06-2024$Medplus Health Services informs about analyst meet Medplus Health Services info
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medplus Health Services has informed that schedule of Analyst/Institutional Investor Meet meeting to be held on Thursday, March 7, 2024 is submitted.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and..
02Mar03-02-2024$Medplus Health Services informs about disclosure Medplus Health Services info
Medplus Health Services has informed that one of the subsidiary of the Company, Optival Health Solutions has received a suspension order from Drugs and Control authorities, under Drugs and Cosmetic Act, 1940 read with rules made thereunder for temporarily suspending the operations of store as mentioned in the table enclosed. Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 details are enclosed.

The above information is a part of company’s filings submitted to BSE.

Medplus Health Services has informed that one of the subsidiary..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit31.880000000000155.4400000000001
Gross Profit 42.4200000000001 75.8600000000001
Operating Profit 126.12294.38
Net Sales 1480.972139.26
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Ajanta Pharma (BSE)
 2377.00 (6.44%)
M.Cap ( in Cr)
29930.39
Alkem Laboratories (BSE)
 4899.45 (2.36%)
M.Cap ( in Cr)
58580.27
Astrazeneca Pharma I (BSE)
 5424.45 (1.70%)
M.Cap ( in Cr)
13561.13
Dr. Reddy's Lab (BSE)
 6349.95 (0.98%)
M.Cap ( in Cr)
105928.76
Torrent Pharma (BSE)
 2732.60 (2.20%)
M.Cap ( in Cr)
92483.60
Shareholding Pattern More
PROMOTERS 40.39 %
NON-INSTITUTION 22.2 %
MUTUAL FUNDS/UTI 12.87 %
FI/BANKS/INSURANCE 0.92 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes